Score pharma logo final
Score pharma logo final 20  20box

Score Pharma, Inc.

Our enhanced monoclonal antibodies will improve patient response rates to provide better therapeutic results.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Exton, PA, USA
  • Currency USD
  • Founded May 2018
  • Employees 3
  • Incorporation Type C-corp
  • Website scorepharma.com

Company Summary

Score Pharma's proprietary CoreX™ technology is the next generation for ADCC enhancement of therapeutic monoclonal antibodies.

Team

  • Bb01d152 d71c 443b a4cb d7746ebb1bfa
    Founder/President/CEO

    Over 30 years experience in Pharmaceutical / Biopharmaceutical Industry; Experienced with major and specialty pharmaceutical environments; Directed drug discovery and disease biology groups;
    Lead CNS stroke/trauma and oncology discovery teams at Cephalon and Regeneron

  • Dbf66afc 2e18 4239 ac51 c841e68575ec
    Co-Founder/EVP - Strategic Affairs/CFO/General Counsel/Secretary

    Over 30 years experience as a life sciences executive/attorney; Extensive record of early-stage company development/growth; Financings (equity, debt, angels/institutions/VC) and partnering/M&A; Skilled in finance, HR, outsourcing, IP strategy, Board support, compliance and record-keeping

  • Default avatar
    Martina Molsbergen
    VP - Business Development

    Martina has closed over 17 out-licensing deals for genetic modification ADCC enhancement technology; Several deals have resulted in products generating multi-billion dollar revenue streams.

Advisors

  • Default avatar
    Martina Molsbergen
    Unconfirmed